By studying the accumulation of tau PET longitudinally after TBI, researchers hope to better understand the role that tauopathy has in the clinical symptomology post TBI, the spatial and temporal dynamics of tau pathology, and to identify interventions that may halt this progression. The gene discussed is MAPT; the disease is tauopathy.